These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


331 related items for PubMed ID: 18363888

  • 1. Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto's thyroiditis*.
    Nielsen CH, Brix TH, Gardas A, Banga JP, Hegedüs L.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):664-8. PubMed ID: 18363888
    [Abstract] [Full Text] [Related]

  • 2. Monozygotic twin pairs discordant for Hashimoto's thyroiditis share a high proportion of thyroid peroxidase autoantibodies to the immunodominant region A. Further evidence for genetic transmission of epitopic "fingerprints".
    Brix TH, Hegedüs L, Gardas A, Banga JP, Nielsen CH.
    Autoimmunity; 2011 May; 44(3):188-94. PubMed ID: 20883148
    [Abstract] [Full Text] [Related]

  • 3. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis.
    Karanikas G, Schuetz M, Wahl K, Paul M, Kontur S, Pietschmann P, Kletter K, Dudczak R, Willheim M.
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):191-6. PubMed ID: 16060913
    [Abstract] [Full Text] [Related]

  • 4. Association of established thyroid peroxidase autoantibody (TPOAb) genetic variants with Hashimoto's thyroiditis.
    Brčić L, Barić A, Gračan S, Brdar D, Torlak Lovrić V, Vidan N, Zemunik T, Polašek O, Barbalić M, Punda A, Boraska Perica V.
    Autoimmunity; 2016 Nov; 49(7):480-485. PubMed ID: 27268232
    [Abstract] [Full Text] [Related]

  • 5. [Clinical validity of anti-thyroperoxidase antibody and anti-thyroglobulin antibody].
    Lian XL, Bai Y, Sun ML, Guo ZS, Dai WX.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):677-81. PubMed ID: 15663231
    [Abstract] [Full Text] [Related]

  • 6. A role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self-antigen, thyroid peroxidase.
    Nielsen CH, Brix TH, Leslie RG, Hegedüs L.
    Clin Immunol; 2009 Nov; 133(2):218-27. PubMed ID: 19726232
    [Abstract] [Full Text] [Related]

  • 7. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients.
    Pedro AB, Romaldini JH, Americo C, Takei K.
    Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):35-8. PubMed ID: 16450315
    [Abstract] [Full Text] [Related]

  • 8. [Effect of iodine and thyroid hormones in the induction and therapy of Hashimoto's thyroiditis].
    Rink T, Schroth HJ, Holle LH, Garth H.
    Nuklearmedizin; 1999 Jan; 38(5):144-9. PubMed ID: 10488481
    [Abstract] [Full Text] [Related]

  • 9. The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified.
    Rebuffat SA, Bresson D, Nguyen B, Péraldi-Roux S.
    Int Immunol; 2006 Jul; 18(7):1091-9. PubMed ID: 16735377
    [Abstract] [Full Text] [Related]

  • 10. Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses.
    Müssig K, Leyhe T, Holzmüller S, Klein R, Weinert C, Saur R, Klingberg S, Häring HU, Gallwitz B.
    Psychoneuroendocrinology; 2009 Sep; 34(8):1252-6. PubMed ID: 19375868
    [Abstract] [Full Text] [Related]

  • 11. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM, Liu W, Lu GH.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):940-2. PubMed ID: 12899792
    [Abstract] [Full Text] [Related]

  • 12. Enhanced oxidative stress in Hashimoto's thyroiditis: inter-relationships to biomarkers of thyroid function.
    Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J.
    Clin Biochem; 2013 Mar 10; 46(4-5):308-12. PubMed ID: 23219737
    [Abstract] [Full Text] [Related]

  • 13. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry.
    Bossowski A, Stasiak-Barmuta A, Czarnocka B, Urban M, Dadan J.
    Autoimmunity; 2005 Dec 10; 38(8):605-11. PubMed ID: 16390813
    [Abstract] [Full Text] [Related]

  • 14. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY, Ho SC, Seah LL, Fong KS, Khoo DH.
    Clin Endocrinol (Oxf); 2004 May 10; 60(5):600-7. PubMed ID: 15104563
    [Abstract] [Full Text] [Related]

  • 15. Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients with Hashimoto's thyroiditis.
    Zaletel K, Krhin B, Gaberscek S, Hojker S.
    Int J Immunogenet; 2006 Apr 10; 33(2):87-91. PubMed ID: 16611252
    [Abstract] [Full Text] [Related]

  • 16. Is there a link between Hashimoto's thyroiditis and primary hyperparathyroidism? A study of serum parathormone and anti-TPO antibodies in 2267 patients.
    Ignjatovic VD, Matovic MD, Vukomanovic VR, Jankovic SM, Džodić RR.
    Hell J Nucl Med; 2013 Apr 10; 16(2):86-90. PubMed ID: 23865082
    [Abstract] [Full Text] [Related]

  • 17. [Estimation of anti-thyroid peroxidase autoantibody (TPOAb) and anti-thyroglobulin autoantibody (TgAb) in patients with various thyroid disease--comparison between histopathological findings and serological results in patients with Hashimoto's thyroiditis].
    Senda Y, Nishibu M, Kawai K, Mizukami Y, Hashimoto T.
    Rinsho Byori; 1995 Dec 10; 43(12):1243-50. PubMed ID: 8569035
    [Abstract] [Full Text] [Related]

  • 18. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure.
    Bülow Pedersen I, Laurberg P, Knudsen N, Jørgensen T, Perrild H, Ovesen L, Rasmussen LB.
    Clin Endocrinol (Oxf); 2005 Jun 10; 62(6):713-20. PubMed ID: 15943834
    [Abstract] [Full Text] [Related]

  • 19. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S, Yu N, Gao Y, Huang W, He Y, Dong B, Lu G, Li M, Cai X, Peng D, Wang Y, Li T, Huang Y, Gao Y, Guo X, Shi B.
    Zhonghua Yi Xue Za Zhi; 2014 Jan 14; 94(2):110-4. PubMed ID: 24721350
    [Abstract] [Full Text] [Related]

  • 20. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
    Mysliwiec J, Oklota M, Nikolajuk A, Waligorski D, Gorska M.
    Immunol Invest; 2007 Jan 14; 36(3):247-57. PubMed ID: 17558708
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.